year 15, Issue 2 (March - April 2021)                   Iran J Med Microbiol 2021, 15(2): 173-188 | Back to browse issues page


XML Persian Abstract Print


1- Department of Biology, Faculty of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran.
2- Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran.
3- Department of Biology, Faculty of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran. , marjan.sabbaghian@gmail.com
Abstract:   (3894 Views)

Background and Objective: Malaria is one of the most life-threatening infectious diseases worldwide. Transmission of the parasite from human to vector mosquitoes is carried out by the gametocyte of the Plasmodium parasite, while these cells are not involved in the symptoms of the disease. The control of the human to mosquito  transmission stage of the parasite life cycle by antigametocyte drugs is currently under increasing scrutiny in an effort to eradicate the disease globally. In this study the gametocytocidal activity of eosin B on asexual blood stages and gametocytes of Plasmodium falciparum has been probed.
Materials and Methods: The parasite Plasmodium falciparum 3D7 was first cultured and then  gametocytogenesis was induced to obtain gametocyte cells. After microscopically studying the developmental stages of the parasite during the culture of the parasite, eosin B was tested on blood and sexual parasites and the viability was assessed by lactate dehydrogenase assay and the results were compared for the two groups.
Results: Mature gametocytes were produced during 12 days. The blood parasites in culture were increased until day 4 and then gradually diminished. The results of lactate dehydrogenase assay showed a stronger effect of eosin B on gametocytes (IC50 = 23 nM) than asexual blood stages (IC50 = 133 nM).
Conclusion: Due to the rarity of anti-gametocyte drugs and importance of these intervention on malaria elimination, eosin B appears to be a suitable candidate for combination therapy against Plasmodium falciparum gametocytes.

Full-Text [PDF 1308 kb]   (1216 Downloads) |   |   Full-Text (HTML)  (1442 Views)  
Type of Study: Original Research Article | Subject: Medical Parasitology
Received: 2020/08/1 | Accepted: 2020/12/27 | ePublished: 2021/04/9

References
1. World Health Organization. "World Malaria Report 2019. 2019." Reference Source. https://www.who.int/malaria/publications/world-malaria-report-2019/en/
2. World Health Organization, Update on the E-2020 Initiative of 21 Malaria-Eliminating Countries, Report and Country Briefs. 2018. Reference Source.
3. https://www.who.int/malaria/publications/atoz/e-2020-progress-report/en/
4. Gaur D, Chitnis CE, Chauhan VS, editors. Advances in malaria research. John Wiley & Sons, Incorporated; 2017. [DOI:10.1002/9781118493816]
5. Biamonte MA, Wanner J, Le Roch KG. Recent advances in malaria drug discovery. Bioorg Med Chem Lett. 2013 May 15;23(10):2829-43. [DOI:10.1016/j.bmcl.2013.03.067] [PMID] [PMCID]
6. Abdul-Ghani R, Basco LK, Beier JC, Mahdy MA. Inclusion of gametocyte parameters in anti-malarial drug efficacy studies: filling a neglected gap needed for malaria elimination. Malar J. 2015 Dec;14(1):1-6. [DOI:10.1186/s12936-015-0936-4] [PMID] [PMCID]
7. Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, White NJ. Activities of artesunate and primaquine against asexual-and sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother. 2004 Apr 1;48(4):1329-34.. [DOI:10.1128/AAC.48.4.1329-1334.2004] [PMID] [PMCID]
8. Staines HM, Krishna S, editors. Treatment and prevention of malaria: antimalarial drug chemistry, action and use. Springer Science & Business Media; 2012 Jan 5. [DOI:10.1007/978-3-0346-0480-2]
9. World Health Organization (2012) Management of severe malaria: a practical handbook, 3rd edn. WHO, Geneva, http://www.who.int/iris/bitstream/10665/79317/1/9789241548526_eng.pdf?ua=1
10. D'alessandro S, Silvestrini F, Dechering K, Corbett Y, Parapini S, Timmerman M, Galastri L, Basilico N, Sauerwein R, Alano P, Taramelli D. A Plasmodium falciparum screening assay for anti-gametocyte drugs based on parasite lactate dehydrogenase detection. J Antimicrob Chemother. 2013 Sep 1;68(9):2048-58. [DOI:10.1093/jac/dkt165] [PMID]
11. Markwalter CF, Davis KM, Wright DW. Immunomagnetic capture and colorimetric detection of malarial biomarker Plasmodium falciparum lactate dehydrogenase. Anal Biochem. 2016 Jan 15;493:30-4. [DOI:10.1016/j.ab.2015.10.003] [PMID]
12. Brown WM, Yowell CA, Hoard A, Vander Jagt TA, Hunsaker LA, Deck LM, Royer RE, Piper RC, Dame JB, Makler MT, Vander Jagt DL. Comparative structural analysis and kinetic properties of lactate dehydrogenases from the four species of human malarial parasites. Biochemistry. 2004 May 25;43(20):6219-29. [DOI:10.1021/bi049892w] [PMID]
13. Iqbal J, Siddique A, Jameel M, Hira PR. Persistent histidine-rich protein 2, parasite lactate dehydrogenase, and panmalarial antigen reactivity after clearance of Plasmodium falciparum monoinfection. J Clin Microbiol. 2004 Sep 1;42(9):4237-41. [DOI:10.1128/JCM.42.9.4237-4241.2004] [PMID] [PMCID]
14. Atreya CE, Johnson EF, Irwin JJ, Dow A, Massimine KM, Coppens I, Stempliuk V, Beverley S, Joiner KA, Shoichet BK, Anderson KS. A molecular docking strategy identifies Eosin B as a non-active site inhibitor of protozoal bifunctional thymidylate synthase-dihydrofolate reductase. J Biol Chem. 2003 Apr 18;278(16):14092-100. [DOI:10.1074/jbc.M212690200] [PMID]
15. Massimine KM, McIntosh MT, Doan LT, Atreya CE, Gromer S, Sirawaraporn W, Elliott DA, Joiner KA, Schirmer RH, Anderson KS. Eosin B as a novel antimalarial agent for drug-resistant Plasmodium falciparum. Antimicrob Agents Chemother. 2006 Sep 1;50(9):3132-41. [DOI:10.1128/AAC.00621-06] [PMID] [PMCID]
16. Zamani Z, Tafreshi AS, Nahrevanian H, Lame-Rad B, Pourfallah F, Eslamifar H, Sadeghi S, Vahabi F, Iravani A, Arjmand M. Efficacy of eosin B as a new antimalarial drug in a murine model. Malar Res Treat. 2012;2012. [DOI:10.1155/2012/381724] [PMID] [PMCID]
17. Federal Register, D&C Red no. 21 and D&C Red no. 22. Federal Register vol. 47, pp. 53843-53846, 1982.
18. Trager W, Jensen JB. Human malaria parasites in continuous culture. J Parasitol. 2005 Jun;91(3):484-6. [DOI:10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2]
19. Allen RJ, Kirk K. Plasmodium falciparum culture: the benefits of shaking. Mol Biochem Parasit. 2010 Jan 1;169(1):63-5. [DOI:10.1016/j.molbiopara.2009.09.005] [PMID]
20. Fivelman QL, McRobert L, Sharp S, Taylor CJ, Saeed M, Swales CA, Sutherland CJ, Baker DA. Improved synchronous production of Plasmodium falciparum gametocytes in vitro. Mol Biochem Parasit. 2007 Jul 1;154(1):119-23. [DOI:10.1016/j.molbiopara.2007.04.008] [PMID]
21. Carter R, Ranford-Cartwright L, Alano P. The culture and preparation of gametocytes of Plasmodium falciparum for immunochemical, molecular, and mosquito infectivity studies. Protocols in Molecular Parasitology. 1993 (pp. 67-88). Humana Press. [DOI:10.1385/0-89603-239-6:67] [PMID]
22. Reader J, Botha M, Theron A, Lauterbach SB, Rossouw C, Engelbrecht D, Wepener M, Smit A, Leroy D, Mancama D, Coetzer TL. Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination. Malar J. 2015 Dec 1;14(1):213. [DOI:10.1186/s12936-015-0718-z] [PMID] [PMCID]
23. Makler MT, Hinrichs DJ. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am J Trop Med Hyg. 1993 Feb 1;48(2):205-10. [DOI:10.4269/ajtmh.1993.48.205] [PMID]
24. Makler MT, Ries JM, Williams JA, Bancroft JE, Piper RC, Gibbins BL, Hinrichs DJ. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med Hyg. 1993 Jun 1;48(6):739-41. [DOI:10.4269/ajtmh.1993.48.739] [PMID]
25. Peatey CL, Spicer TP, Hodder PS, Trenholme KR, Gardiner DL. A high-throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes. Mol Biochem Parasit. 2011 Dec 1;180(2):127-31. [DOI:10.1016/j.molbiopara.2011.09.002] [PMID]
26. Ngwa C, Rosa TF, Pradel G. The biology of malaria gametocytes. Current Topics in Malaria. 2016 Nov 30:117-44. [DOI:10.5772/65464]
27. Dechy-Cabaret O, Benoit-Vical F. Effects of antimalarial molecules on the gametocyte stage of Plasmodium falciparum: the debate. J Med Chem. 2012 Dec 13;55(23):10328-44. [DOI:10.1021/jm3005898] [PMID]
28. Adjalley SH, Johnston GL, Li T, Eastman RT, Ekland EH, Eappen AG, Richman A, Sim BK, Lee MC, Hoffman SL, Fidock DA. Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. P Natl A Sci. 2011 Nov 22;108(47):E1214-23. [DOI:10.1073/pnas.1112037108] [PMID] [PMCID]
29. Wadi I, Pillai CR, Anvikar AR, Sinha A, Nath M, Valecha N. Methylene blue induced morphological deformations in Plasmodium falciparum gametocytes: implications for transmission-blocking. Malar J. 2018 Dec 1;17(1):11. [DOI:10.1186/s12936-017-2153-9] [PMID] [PMCID]
30. Peatey CL, Skinner-Adams TS, Dixon MW, McCarthy JS, Gardiner DL, Trenholme KR. Effect of antimalarial drugs on Plasmodium falciparum gametocytes. J Infect Dis. 2009 Nov 15;200(10):1518-21. [DOI:10.1086/644645] [PMID]
31. Delves MJ, Straschil U, Ruecker A, Miguel-Blanco C, Marques S, Dufour AC, Baum J, Sinden RE. Routine in vitro culture of P. falciparum gametocytes to evaluate novel transmission-blocking interventions. Nat Protoc. 2016 Sep;11(9):1668-80. [DOI:10.1038/nprot.2016.096] [PMID]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.